First, PACLseq was designed to detect seven gene‐related fusion genes in Ph‐like ALL (ABL2, CSF1R, PDGFRB, JAK2, ABL1, EPOR, and CRLF2), with a detection capability encompassing 97.6% of cases with fusion genes [30]. The gene discussed is ABL2; the disease is acute lymphoblastic leukemia.